Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Annals of Family Medicine|March 24, 2026
Antithrombotic Therapy Discontinuation, Bleeding, and Thromboembolic Events in Patients With Cancer During the Last Phase of Life: Insights From Primary Care RecordsDenise Abbel, Geert-Jan Geersing, Emmy M Trinks-Roerdink, et al.
Research and Practice in Thrombosis and Haemostasis|February 9, 2026
Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC StudyGabrielle Sarlon-Bartoli, Barbara Leclercq, Nathalie Trillot, et al.
Eclinicalmedicine|September 21, 2023
The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysisMarte A M van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, et al.
Thrombosis Research|January 18, 2026
Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study, Isabelle Mahé, Skerdi Haviari, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis DayNicola Potere, Stefano Barco, Isabelle Mahé, et al.
Thrombosis and Haemostasis|January 24, 2025
Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting DiseaseEva K Kempers, Chantal Visser, Eric C T Geijteman, et al.
Hemasphere|May 20, 2025
Quality of vitamin K antagonist treatment during the last year of lifeChantal Visser, Eva K Kempers, Jamilla Goedgebuur, et al.
The New England Journal of Medicine|March 31, 2025
Extended Reduced-Dose Apixaban for Cancer-Associated Venous ThromboembolismIsabelle Mahé, Marc Carrier, Didier Mayeur, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2026
Global survey of women's awareness of pregnancy- and postpartum-associated venous thromboembolism (World Thrombosis Day 2025)Marcello Di Nisio, Isabelle Mahé, Parham Sadeghipour, et al.
NEJM Evidence|February 6, 2024
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical PatientsDominique Mottier, Philippe Girard, Francis Couturaud, et al.
Pageof 15